Health

GLP-1 Medicines Explained: What They Are and What to Know

Medicines like semaglutide and tirzepatide are changing how obesity and diabetes are treated. Here is how they work, what trials showed, the side effects, and why they are not a shortcut.

PreMinuteOct 12, 2026 · 3 min read
GLP-1 Medicines Explained: What They Are and What to Know

You may have heard names like Ozempic, Wegovy, or Mounjaro in the news. They belong to a family of medicines that copy a natural hormone called GLP-1. They are some of the most talked-about drugs in the world today. This article explains the basics in plain words.

What is GLP-1?

GLP-1 is a hormone your gut releases after you eat. It tells your pancreas to release insulin, slows down how fast your stomach empties, and sends a "full" signal to your brain. GLP-1 medicines copy this effect, but last much longer in the body than the natural hormone.

They were first approved for type 2 diabetes. Some are also approved for weight management in people with obesity, or with overweight and a related health condition.

What trials have shown

In large clinical trials, people taking weekly semaglutide 2.4 mg lost on average about 15 percent of their body weight over around 68 weeks, compared with roughly 2 percent on placebo. In a trial of tirzepatide, the highest dose led to an average weight loss of around 20 percent over about 72 weeks. Both trials combined the medicines with diet and activity advice. Individual results vary a lot.

Common side effects

Who should consider them?

  1. Talk to a doctor first

    These are prescription medicines that need a medical check, not something to buy online.

  2. Match them to a health reason

    They are meant for people with diabetes or obesity-related health risks, not for small cosmetic weight loss.

  3. Build habits alongside

    Eat enough protein, stay active, and strengthen your muscles to protect muscle mass.

  4. Plan for the long term

    Ask about how long you will take it, how to stop, and what happens afterwards.

What most people miss

Sources

More in Health

World Diabetes Day: Why India's 101 Million Cases Need Early Action
Health

World Diabetes Day: Why India's 101 Million Cases Need Early Action

World Diabetes Day falls on 14 November. This year's theme is early action. Here is what diabetes actually is, India's numbers, and the warning signs people miss.

PreMinuteNov 13, 2026 · 6 min read
Desk Ergonomics: How to Set Up Your Workspace to Avoid Pain
Health

Desk Ergonomics: How to Set Up Your Workspace to Avoid Pain

A bad desk setup slowly causes neck, back and wrist pain. Learn the official chair, monitor and keyboard rules from OSHA and CCOHS, and how often to take breaks.

PreMinuteNov 12, 2026 · 5 min read
Delhi Under GRAP Stage III: What Changed From Stage II
Health

Delhi Under GRAP Stage III: What Changed From Stage II

Delhi-NCR's AQI hit 382 this week and CAQM invoked GRAP Stage III. Here is what is newly banned, why it happened just before Diwali, and how to stay safe.

PreMinuteNov 9, 2026 · 5 min read

Keep reading

Digital Arrest Scams: What the Supreme Court Just Ordered
Technology

Digital Arrest Scams: What the Supreme Court Just Ordered

India's Supreme Court has told WhatsApp and banks to detail how they will stop "digital arrest" fraud. Here is how the scam works and how to protect yourself.

PreMinuteNov 14, 2026 · 5 min read
India's CNAP Caller Name Rule: What Changes on Your Phone
Technology

India's CNAP Caller Name Rule: What Changes on Your Phone

From 1 November 2026, calls from unsaved numbers can show the caller's registered name on 4G and 5G networks. Here is what you will see, who is left out, and what to do.

PreMinuteNov 13, 2026 · 5 min read
How Encryption Works: From Plain Text to Secret Code
Technology

How Encryption Works: From Plain Text to Secret Code

Encryption scrambles your data so only the right key can read it. Learn how symmetric and public-key encryption work together, where HTTPS uses them, and what encryption cannot protect you from.

PreMinuteNov 13, 2026 · 5 min read